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Background
Musculoskeletal ultrasound (US) is a rapidly evolving and
powerful diagnostic modality, which is gaining popularity
for the evaluation and management of joint damage and
soft tissue diseases in children with JIA. Several studies
have shown that clinical examination underestimates the
presence of intra-articular fluid when compared to US. US
guided aspiration allows direct observation of the joint
effusion and needle placement and enables correct intra-
articular corticosteroid injection avoiding the risk of ster-
oid-induced subcutaneous atrophy. This contrasts X-ray
guided techniques. In small joints such as MCP, PIP and
MTP the effusion is mainly located proximal to the joint
space.
Methods
US standard scans were performed with B-mode using a
linear 6–14 MHz transducer (Hitachi EUB-6500 CFM).
Results
US guided steroid injections in small (MCP, PIP, MTP)
and large (hip, knee, ankle, wrist, elbow) joints in JIA
more than 50 patients were performed in the periode
December 2007 to April 2008. In children with systemic
JIA with massively swollen joints we found that US dis-
closed surprisingly modest fluid effusion compared to
severe synovial hypertrophy. Corticosteroid induced atro-
phy were not noticed.
Conclusion
In our experience US improves correct needle placement
in the joint space and US guided procedures seem to be
superior to conventional injection and aspiration tech-
niques. Implementation of US guided injections in rou-
tine pediatric rheumatology practice will conceivably
allow improved treatment results and decrease the risk of
iatrogenic complications.
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